Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008813
Filing Date
2021-04-15
Accepted
2021-04-15 08:00:57
Documents
100
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2131505
2 ex10-47.htm EX-10.47 214877
3 ex10-48.htm EX-10.48 237659
4 ex31-1.htm EX-31.1 11051
5 ex31-2.htm EX-31.2 11046
6 ex32-1.htm EX-32.1 6866
7 ex32-2.htm EX-32.2 6859
  Complete submission text file 0001493152-21-008813.txt   8696652

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cdxi-20201231.xml EX-101.INS 1166172
9 XBRL SCHEMA FILE cdxi-20201231.xsd EX-101.SCH 80298
10 XBRL CALCULATION FILE cdxi-20201231_cal.xml EX-101.CAL 92035
11 XBRL DEFINITION FILE cdxi-20201231_def.xml EX-101.DEF 322847
12 XBRL LABEL FILE cdxi-20201231_lab.xml EX-101.LAB 540269
13 XBRL PRESENTATION FILE cdxi-20201231_pre.xml EX-101.PRE 465895
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-181719 | Film No.: 21827333
SIC: 2834 Pharmaceutical Preparations